CSHL 2015 Telomeres & Telomerase Conference
CSHL 2015 端粒
基本信息
- 批准号:8900591
- 负责人:
- 金额:$ 0.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-06 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAnemiaAnimal ModelAreaAsiansAttentionAwardBasic ScienceBiochemicalBiological ModelsBiological SciencesBiologyBirdsCancer DiagnosticsCell AgingCell CycleCell MaintenanceCell ProliferationChickensChromosomal InstabilityChromosomesClinicalComplexDNADNA DamageDNA RepairDNA biosynthesisDataDevelopmentDiagnosisDiseaseEnsureEnvironmentEnzymesEukaryotaEuropeanFacultyFibrosisFission YeastFosteringFutureGenetic RecombinationGenomicsGrowthHumanIndividualInternationalLaboratoriesLength of StayLiver CirrhosisLungMalignant NeoplasmsMedicineMeiosisMolecular GeneticsMusNematodaNobel PrizeOralOrganismPancytopeniaParticipantPhysiologyPlantsPlayPostdoctoral FellowPredispositionPremature aging syndromePrizeProcessProteinsProtozoaPublicationsRNARanaRecording of previous eventsResearchResearch InstituteResearch PersonnelRoleSaccharomycetalesScheduleScientistSeriesStem cellsSymptomsSyndromeSystemTelomeraseTherapeuticWomanWorkabstractingbaseflyfungusgraduate studentinnovationinsightinterestlaboratory facilitymeeting abstractsmeetingsposterspublic health relevancerepairedresponsesuccesssymposiumtelomerase reverse transcriptasetelomereunpublished works
项目摘要
DESCRIPTION (provided by applicant): Cold Spring Harbor Laboratory Conference on Telomeres and Telomerase April 28 - May 2, 2015. Telomeres are specialized protein-DNA complexes that protect the ends of eukaryotic chromosomes. In most eukaryotes, telomeres contain short DNA repeats that are maintained by the telomerase reverse transcriptase. Since telomerase counteracts the terminal sequence loss that accompanies replication of linear DNA, this enzyme is required for long-term cellular proliferation. The field of telomere biology grew rapidly once it was recognized that telomere dynamics and telomerase activation play a pivotal role in human cancer and in cellular senescence. A further impetus to the growth of this field has been the recognition of a rapidly increasing range of clinical syndromes resulting from short telomeres. As a result, the telomere field is now a highly diverse and dynamic research area, representing a wide variety of research interests (aging, telomere syndromes, stem cells, cell cycle, meiosis, recombination, replication, etc.) as well as a strong emphasis on cancer suppression, development, progression, diagnosis and treatment. Although a major part of the field works with mouse and human systems, it also benefits from insights gained from study of a wide variety of different model organisms (birds, frogs, flies, plants, nematodes, protozoa, budding yeast, fission yeast, and other fungi). The success of basic research in telomere biology was highlighted by the awarding of the 2009 Nobel Prize in Medicine/Physiology to Elizabeth Blackburn, Carol Greider, and Jack Szostak for their pioneering work in the discovery of telomerase as well as the Breakthrough Prize in Life Sciences and the Gairdner award to the current meeting co-organizer Titia de Lange for her work on telomere protection. The previous eight Cold Spring Harbor Laboratory meetings on Telomeres and Telomerase have been crucial in bringing together a diverse group of researchers from all parts of the world, and have resulted in vigorous discussion and synergistic interactions stimulated by the presentation of mostly unpublished data. Because the CSHL Telomeres and Telomerase conference remains the only opportunity for scientists in this rapidly growing field to interact as a whole, this meeting is unique and of the utmost importance for the future of the field. Moreover, the format of CSHL meetings, for which nearly all talks are chosen from submitted abstracts, maximizes the opportunity for new independent investigators, postdocs and graduate students to present their work in a highly visible venue. These meetings have all had a uniformly high attendance rate from an international group of researchers. The podium and poster presentations at the past meetings presented the major discoveries in the field well before publication. We expect that the 2015 meeting will be equally well attended.
描述(申请人提供):2015年4月28日至5月2日,冷泉港端粒和端粒酶实验室会议。端粒是一种特殊的蛋白质-DNA复合体,保护真核染色体的末端。在大多数真核生物中,端粒包含由端粒酶逆转录酶维持的短DNA重复序列。由于端粒酶抵消了伴随线性DNA复制的末端序列丢失,这种酶是细胞长期增殖所必需的。自从人们认识到端粒动力学和端粒酶激活在人类癌症和细胞衰老中起着关键作用后,端粒生物学领域迅速发展起来。这一领域发展的另一个推动力是人们认识到由于端粒过短而导致的临床症状范围迅速增加。因此,端粒领域现在是一个高度多样化和动态的研究领域,代表了广泛的研究兴趣(衰老、端粒综合征、干细胞、细胞周期、减数分裂、重组、复制等)。以及对癌症的抑制、发展、进展、诊断和治疗的高度重视。虽然该领域的主要部分与老鼠和人类系统一起工作,但它也受益于对各种不同模式生物(鸟类、青蛙、苍蝇、植物、线虫、原生动物、萌芽酵母、分裂酵母和其他真菌)的研究。2009年诺贝尔医学/生理学奖授予伊丽莎白·布莱克本、卡罗尔·格雷德和杰克·绍斯塔克,以表彰他们在发现端粒酶方面的开创性工作,并将生命科学突破奖和盖尔德纳奖授予本次会议的联合组织者蒂蒂娅·德兰格,以表彰她在端粒保护方面的工作,这突显了端粒生物学基础研究的成功。之前关于端粒和端粒酶的八次冷泉港实验室会议对于将来自世界各地的不同研究人员聚集在一起起到了至关重要的作用,并由于提出了大多数未公布的数据而导致了激烈的讨论和协同互动。由于CSHL端粒和端粒酶会议仍然是这一快速增长领域的科学家作为一个整体进行互动的唯一机会,因此这次会议是独一无二的,对该领域的未来至关重要。此外,CSHL会议的形式--几乎所有的演讲都是从提交的摘要中挑选出来的--最大限度地为新的独立调查人员、博士后和研究生提供了在一个非常显眼的场所介绍他们的工作的机会。所有这些会议都有一个国际研究小组一致的高出席率。在过去几次会议上的讲台和海报介绍在出版之前很久就介绍了该领域的主要发现。我们预计,2015年会议的出席人数也将同样多。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J. STEWART其他文献
DAVID J. STEWART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J. STEWART', 18)}}的其他基金
CSHL Single Cell Analysis Course (2023-2027)
CSHL单细胞分析课程(2023-2027)
- 批准号:
10627446 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Eukaryotic DNA Replication and Genome Maintenance Conference
CSHL 2023真核DNA复制与基因组维护会议
- 批准号:
10677192 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Eukaryotic mRNA Processing Conference
CSHL 2023真核mRNA加工会议
- 批准号:
10679367 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Conference on Biology of Cancer: Microenvironment & Metastasis
CSHL 2023癌症生物学会议:微环境
- 批准号:
10750261 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Mechanisms of Metabolic Signaling Conference
CSHL 2023代谢信号机制会议
- 批准号:
10751346 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Neurobiology of Drosophila Conference
CSHL 2023果蝇神经生物学会议
- 批准号:
10669936 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL 2023 Conference on Microbial Pathogenesis & Host Response
CSHL 2023微生物发病机制会议
- 批准号:
10675902 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
CSHL The Biology of Genomes Conference (2023-2027)
CSHL基因组生物学会议(2023-2027)
- 批准号:
10608266 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别: